Back
Matinas BioPharma Holdings, Inc. 10K Form
Sell
16
MTNB
Matinas BioPharma Holdings, Inc.
Last Price:
$0.78
Seasonality Move:
1.63%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MTNB News And Ratings
See the #1 stock for the next 7 days that we like better than MTNB
MTNB Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-1.5M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.09 |
| Price / Book: | 0.78 |
Profitability
| EPS (TTM): | -3.40990 |
|---|---|
| Net Income (TTM): | $-17.5M |
| Gross Margin: | $-972K |
| Return on Equity: | -199.71% |
| Return on Assets: | -131.71% |
Matinas BioPharma Holdings, Inc. Earnings Forecast
Key Matinas BioPharma Holdings, Inc. Financial Ratios
-
Per Share Earnings over the last 12 years have been positive in 7 years.
Matinas BioPharma Holdings, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYAM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | MTNB |
| Website: | matinasbiopharma.com |
Debt
| Debt-to-Equity Ratio: | 0.36 |
|---|---|
| Current Ratio: | 3.78 |
| Quick Ratio: | 3.67 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
MTNB Technical Analysis vs Fundamental Analysis
Sell
16
Matinas BioPharma Holdings, Inc. (MTNB)
is a Sell
Is Matinas BioPharma Holdings, Inc. a Buy or a Sell?
-
Matinas BioPharma Holdings, Inc. stock is rated a SellThe current Matinas BioPharma Holdings, Inc. [MTNB] share price is $0.79. The Score for MTNB is 16, which is 68% below its historic median score of 50, and infers higher risk than normal.